Lexel – Nestor Rava, CEO – Argentina
The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. Why did Lexel enter…
Savant is aware that health is people’s most valuable asset, and seeks to provide patients with drugs that allow them to enjoy a better quality of life.
At only 20 years of age, it has become a company of international renown that works every day to offer more health and a better life to millions of people, from Argentina to the rest of the world. This achievement has been possible due to the excellence and determination of their staff, made up of more than 350 workers from different areas. Having a production based on international quality standards, extraordinary technological skills, a manufacturing facility equipped with leading-edge technology and strategically located corporate headquarters, they strive to attain a maximum-efficiency industrial and business process.
SAVANT has a model manufacturing plant, located in a 110,000-m² area in the town of El Tío, Córdoba, Argentina, where proprietary drugs in various pharmaceutical forms are produced: solid (tablets, film-coated tablets, and capsules), semi-solid (soft capsules and granules), and liquid (syrups, suspensions). The company also has a dedicated facility for producing antibiotics in solid dosage forms, such as film-coated tablets and extemporaneous compounding with beta-lactam active ingredients and clavulanic acid combinations, and a soft capsule facility with a capacity of 150,000 units per hour, being among the most important plants of these characteristics in the country.
Address
Esteban Echeverria 1050
Vicente Lopez
Buenos Aires B1602ABC
Argentina
(+54) 11 4730 4606
The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. Why did Lexel enter…
Carlos Chiale, National Administrator of ANMAT, discusses the agency’s latest strategy implementation and its pioneering work in the area of fighting drug falsification. Could you provide a historical overview…
The general manager of Sandoz South Latam weighs up the factors that have allowed his company to be the leader in biosimilars and differentiated generics. Could you please…
The vice president of Laboratorios Beta discusses the factors of why his organization is on the way to consolidating its different business lines and becoming a pure pharmaceutical company. …
The general director of pharma in Argentina for the Bagó group explains why his group has planned that 75 percent of turnover will come from international markets in the coming years. 2014 marks…
The executive coordinator of GACTEC maps the current level of science and technology in Argentina and outlines the country’s ambitions in this area, which is to have an impact on innovation at…
The President of Argenomics highlights the position of his company as the bridge between science and business in Argentina. Could you please provide an historical overview of Argenomics? Several…
The general manager of Ferring Argentina believes that the country has one of the strongest social security systems in Latin America, with high reimbursement levels and coverage for most chronic…
The general manager of Roche Argentina weighs up the factors that have allowed the country to be included among the top three performing markets in the region for Roche, and…
The general manager of Gennoma Laboratorios Argentina weighs up the factors of why raising brand awareness using public television is the key success to his company communication strategy. When…
“In the last decade, as a result of high and sustained growth, the Argentine pharmaceutical industry increased production by more than 240 percent, which speaks volumes about the capacity of…
The country president of AstraZeneca Argentina discusses the country’s patent laws, the work being done to bring innovation back to Argentina, and the challenge of a strong branded generics market…
See our Cookie Privacy Policy Here
